Plain-English translation of NCT07111637 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a software tool called icobrain ms that uses artificial intelligence to help doctors analyze brain MRI scans in people with multiple sclerosis. The AI software is designed to detect small changes in the brain that might be missed during regular visual inspection of scans, helping doctors make better decisions about your treatment. Researchers hope to show that this technology can improve how well MS is monitored in the NHS.
Currently, radiologists examine MS brain scans by eye, which can miss important changes due to human fatigue, time pressure, and inconsistent scanning methods across hospitals. Research suggests this new treatment could detect new brain lesions 3–4 times more effectively than traditional visual inspection alone.
You likely qualify if…
You likely don't qualify if…
You will have brain MRI scans as part of your regular MS care. Your scans will be analyzed both by a radiologist in the traditional way and with the help of the AI software. The study compares how well each method detects changes in your brain to determine if the AI tool improves monitoring and treatment decisions. You'll need to be able to access a smartphone, tablet, or computer to participate.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
United Kingdom